Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Abstracto

Understanding the Psychopharmacology of Schizophrenia: Advancements and Challenges

Raja Prabhu

This abstract summarizes the advancements in understanding and treating neurological disorders. It highlights the emergence of precision medicine, which tailors treatments to individual patients based on their unique genetic makeup and lifestyle. It also discusses the revolutionary impact of Deep Brain Stimulation (DBS) in alleviating symptoms of movement disorders. The potential of gene therapy to address genetic abnormalities associated with neurological disorders is explored, along with recent advancements in gene editing techniques. Additionally, the use of neurostimulation and neurofeedback to modulate brain activity and promote neural plasticity is highlighted. Overall, these advancements offer hope for improved patient care and management in the field of neurological disorders.